Back to Search
ELIZABETH SHARPE, M.D.
M.D.
Ophthalmology Physician
NPI: 1316903214Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
10243(SC)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.
PMID 15205246·Br J Ophthalmol·2004
3-trial
A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.
PMID 18627340·J Ocul Pharmacol Ther·2008
4-observational
Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
PMID 15094733·Eye (Lond)·2005
3-trial
Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.
PMID 11877334·Br J Pharmacol·2002
7-preclinical
Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension.
PMID 17917683·Eye (Lond)·2009
3-trial
Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy.
PMID 18039347·Acta Ophthalmol·2008
3-trial
Heat shock protein 90-binding agents protect renal cells from oxidative stress and reduce kidney ischemia-reperfusion injury.
PMID 18562631·Am J Physiol Renal Physiol·2008
7-preclinical
Tiny patients, tiny dressings: a guide to the neonatal PICC dressing change.
PMID 18535420·Adv Neonatal Care·2008
8-other
Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer.
PMID 17955490·Int J Cancer·2008
8-other
The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
PMID 18085467·Curr Eye Res·2007
4-observational
The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients.
PMID 15933751·Eye (Lond)·2006
4-observational
Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis.
PMID 16772326·Am J Physiol Endocrinol Metab·2006
7-preclinical
VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
PMID 16754748·FASEB J·2006
7-preclinical
The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells.
PMID 16651636·Am J Pathol·2006
7-preclinical
Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma.
PMID 16044139·Bone Marrow Transplant·2005
3-trial
A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.
PMID 15650513·J Ocul Pharmacol Ther·2004
3-trial
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
PMID 15037890·Eye (Lond)·2004
3-trial
Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.
PMID 12780402·Acta Ophthalmol Scand·2003
3-trial
Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
PMID 12566015·Am J Ophthalmol·2003
3-trial
The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%.
PMID 12434307·Curr Eye Res·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 242 MATHIS FERRY RD STE 100
MT PLEASANT, SC 29464 - Phone
- (843) 884-1011
Quick Facts
- NPI
- 1316903214
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile